Both in Pharmaceuticals
Grace Therapeutics vs Elicio Therapeutics
Over the past year GRCE returned −38.0% and ELTX returned −80.3%; their daily moves had a correlation of 0.03.
GRCE −38.0% ELTX −80.3%Growth of $1, one year, split-adjusted
| Metric | GRCE | ELTX |
|---|---|---|
| Price | $1.92 | $1.94 |
| Market cap | $40.3M | $52.6M |
| Today | −2.79% | +16.17% |
| 1 month | −9.7% | +3.7% |
| 6 months | −18.5% | −83.6% |
| Year to date | −44.7% | −75.6% |
| 1 year | −39.2% | −79.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $13.8M | $13.9M |
| Dividend yield | — | — |
| Volatility (60d) | 36.6% | 66.6% |
| Short % of float | 11.4% | 19.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).